Drug discovery:: Here comes the worm

被引:20
作者
Segalat, Laurent [1 ]
机构
[1] Univ Lyon, CNRS, UMR 5534, Lyon, France
关键词
D O I
10.1021/cb600221m
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Identification of bioactive molecules and their targets impedes the process of drug development. In a recent paper, a genetically tractable organism, the Caenorhabditis elegans worm, is shown to be a viable screening system in which the drug target and the pathway it activates can be readily identified.
引用
收藏
页码:277 / 278
页数:2
相关论文
共 4 条
[1]  
GAUD A, 2004, NEUROMUSCLAR DISORD, V4, P365
[2]   A small-molecule screen in C-elegans yields a new calcium channel antagonist [J].
Kwok, TCY ;
Ricker, N ;
Fraser, R ;
Chan, AW ;
Burns, A ;
Stanley, EF ;
McCourt, P ;
Cutler, SR ;
Roy, PJ .
NATURE, 2006, 441 (7089) :91-95
[3]   Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons [J].
Parker, JA ;
Arango, M ;
Abderrahmane, S ;
Lambert, E ;
Tourette, C ;
Catoire, H ;
Néri, C .
NATURE GENETICS, 2005, 37 (04) :349-350
[4]   Prednisone in dystrophin-deficient Caernorabditis elegans -: Reply [J].
Ségalat, L .
NEUROMUSCULAR DISORDERS, 2004, 14 (10) :698-698